Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003.

[1]  C. Norris,et al.  Safety of percutaneous coronary interventions without on-site cardiac surgery: A recent 10-year experience of 5,909 cases , 2003 .

[2]  D. Moliterno,et al.  Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET. , 2003, Journal of the American College of Cardiology.

[3]  S. Ellis,et al.  Emergency Coronary Artery Bypass Surgery in the Contemporary Percutaneous Coronary Intervention Era , 2002, Circulation.

[4]  B. Gersh,et al.  Rationale for on-site cardiac surgery for primary angioplasty: a time for reappraisal. , 2002, Journal of the American College of Cardiology.

[5]  J. Tcheng,et al.  Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial. , 2001, American Journal of Cardiology.

[6]  V. Hasselblad,et al.  Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. , 2001, JAMA.

[7]  A. Jacobs,et al.  Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries , 2000, Circulation.

[8]  M. Bell,et al.  Improving outcome over time of percutaneous coronary interventions in unstable angina. , 2000, Journal of the American College of Cardiology.

[9]  Bruce R. Brodie,et al.  Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction : In-hospital and 30-day results of the PAMI stent pilot trial , 1998 .

[10]  A. Jacobs,et al.  Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. , 1997, The Annals of thoracic surgery.

[11]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[12]  E. Hannan,et al.  Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. , 1996, American heart journal.

[13]  J. Piehler,et al.  Risk analysis of operative intervention for failed coronary angioplasty. , 1992, The Annals of thoracic surgery.

[14]  E. Jones,et al.  Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty. A 10-year experience. , 1992, Annals of surgery.

[15]  N. Stamato,et al.  Emergency operation after failed angioplasty. , 1988, The Journal of thoracic and cardiovascular surgery.

[16]  F. Loop,et al.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.

[17]  V. Parsonnet,et al.  Emergency operation after failed angioplasty. , 1988, The Journal of thoracic and cardiovascular surgery.

[18]  S. Kelsey,et al.  Emergency coronary bypass surgery after coronary angioplasty: the National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry experience. , 1984, The American journal of cardiology.